Trial intelligence / Profile preview

Bumetanide for Children with Autism Spectrum Disorder (Historical Control Study)

ChiCTR-OPC-16008336Phase 4Recruiting

Sponsor
Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of bumetanide in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine. Started Apr 2016; status: recruiting.

02

Drugs

bumetanide
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on ChiCTR-OPC-16008336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-16008336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call